Cancer Second Opinion

Massive Bio’s number one priority is to create positive outcomes for cancer patients. With the Clinical Trial Matching Service and Virtual Tumor Board, you are one-step closer to reaching that positive outcome. The Virtual Tumor Board provides you with a team of cancer specialists from the world’s largest cancer research centers.

Cancer clinical trials are important for cancer treatment; they find and prove new ways to fight cancer. By participating in a clinical trial, you can find the best treatment for your or your loved one and help others who may be struggling with cancer. Our team of experts that forms the Virtual Tumor Board use our Artificial Intelligence-based platform, along with their expert oncologist opinions, to provide unique clinical trial options to your specific case.

Getting access to the right clinical trials and right treatments shouldn’t have to be overwhelming. That’s why Massive Bio uses the clinical trial matching service to match cancer patients to the right clinical trials based on the stage of disease, biomarker status, geographical location and past medical history.

Download on the App Store ®Get it on Google Play

Why Get A Virtual Tumor Board?

Our Virtual Tumor Board (VTB) is composed of a team of 3 or more physicians who review your case and medical history in order to offer an expert analysis for treatment options.

Our VTB is also backed with our SYNERGY Artificial Intelligence (AI) platform that has access to over 30,000 active clinical trials and to the latest information available in order to provide the most personalized treatment possible. Our team’s priority is to provide you with a positive outcome.


Do You Have Any Questions?

  • Be one step closer to unlocking cancer treatment options.
  • A second opinion without leaving home by US oncologists.
  • Explore options for therapy when you have relapsed or current therapy has failed.
  • Access to clinical trials & immunotherapy options where appropriate.

    By submitting, you agree to our Terms And Conditions and have read and acknowledged our Privacy Statement.

    Contact Us to Help You

    11 May 2021

    Clinical Trials for TP53 Wild Type Tumors

    Clinical Trials for TP53 Wild Type Tumors: TP53 is dysregulated in a majority of human solid and hematological tumors. TP53 directly or indirectly regulates multiple cellular functions including cell cycle, apoptosis, DNA repair, and cellular senescence. TP53 dysregulation can generally be attributed to two factors: Somatic or germline mutations of TP53 Excessive negative regulation of wild type TP53 by MDM2/MDM4 genes What is the TP53 Mutation? Over 50% of tumors have mutations in TP53 which leads to the loss of tumor suppressor function of the protein leaving the cell more vulnerable to physiological stresses leading to tumorigenesis. Several pharmaceutical companies are investigating small molecules that restore the function of TP53 to overcome loss of function mutations; these clinical trials are…
    Clinical Trials for TP53 Wild Type Tumors
    Myelofibrosis Symptoms
    27 Feb 2021

    Myelofibrosis Symptoms

    How to understand Myelofibrosis Symptoms? Myelofibrosis is an uncommon type of bone marrow cancer that disrupts your body's normal production of blood cells. This disease occurs when bone marrow stem cells develop mutations in their DNA and affects approximately 1.5 cases per 100,000 people. The end outcome is usually an overproduction of blood cells from a malfunctioning spleen or a lack of red blood cells, which causes anemia. Patients may identify a range of myelofibrosis symptoms, from mild to severe, as a result of the normally spongy bone marrow becoming thick and scarred. Are Myelofibrosis Symptoms associated with other bone marrow diseases? Myelofibrosis is called primary myelofibrosis when it develops on its own and not as a result of another…


    Frequently Asked Questions